Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
GLP-1 receptor agonists such as liraglutide, semaglutide, and dulaglutide have shown significant reductions in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, primarily in people with established cardiovascular disease or high cardiovascular risk
Dial (816) 208-4330 to request an upcoming visit to our office to learn more about weight-reducing injections to pair with a healthy diet and lifestyle for optimum results!
Strawn JR, DAlessio DA, Keck PE, Seeley RJ
To avoid dosing errors and potential overdose, never use a syringe to remove Tresiba from the Tresiba FlexTouch disposable insulin prefilled pen
